No abstract

No abstract

to innovative devices (81% of them). While they are less frequent for medical devices with no added medical value (22%). Price-volume agreements are the most commonly used (71%), followed by simple discount (16%) and performance-based agreement (7%). When considering the distribution channel, inpatient medical devices are more entitled to be associated to a MEA than outpatient devices. In terms of therapeutic area, devices in cardiology and neurology ranks first in MEA use. Conclusions: CEPS increasingly uses MEA as a regulation tool to contain reimbursed medical devices expenditures.

No abstract

No abstract